CASP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.422770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.481780E-01
Normal-vs-Stage2
1.870950E-01
Normal-vs-Stage3
9.489900E-02
Normal-vs-Stage4
3.696800E-01
Stage1-vs-Stage2
6.505200E-01
Stage1-vs-Stage3
1.191770E-01
Stage1-vs-Stage4
9.648200E-01
Stage2-vs-Stage3
4.947900E-02
Stage2-vs-Stage4
6.768600E-01
Stage3-vs-Stage4
3.687400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.482380E-01
Normal-vs-AfricanAmerican
6.121200E-01
Normal-vs-Asian
9.836400E-02
Caucasian-vs-AfricanAmerican
3.775200E-01
Caucasian-vs-Asian
4.627000E-01
AfricanAmerican-vs-Asian
2.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.486250E-01
Normal-vs-Female
1.492010E-01
Male-vs-Female
9.949800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.528600E-01
Normal-vs-Age(41-60Yrs)
2.863200E-01
Normal-vs-Age(61-80Yrs)
1.134620E-01
Normal-vs-Age(81-100Yrs)
8.917800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.459400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.704600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.157800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.163700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.443900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.318000E-01
Normal-vs-Daily Drinker
1.771030E-01
Normal-vs-Weekly Drinker
3.101000E-01
Normal-vs-Occasional Drinker
2.246200E-01
Normal-vs-Social Drinker
3.426800E-01
Non Drinker-vs-Daily Drinker
6.247200E-01
Non Drinker-vs-Weekly Drinker
9.330400E-01
Non Drinker-vs-Occasional Drinker
8.909600E-01
Non Drinker-vs-Social Drinker
4.760200E-01
Daily Drinker-vs-Weekly Drinker
6.374000E-01
Daily Drinker-vs-Occasional Drinker
5.570600E-01
Daily Drinker-vs-Social Drinker
2.671600E-01
Weekly Drinker-vs-Occasional Drinker
9.736600E-01
Weekly Drinker-vs-Social Drinker
5.955800E-01
Occasional Drinker-vs-Social Drinker
5.537600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.949800E-01
Normal-vs-Grade 2
9.775800E-01
Normal-vs-Grade 3
9.525400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.795300E-03
Grade 1-vs-Grade 3
5.523300E-03
Grade 1-vs-Grade 4
8.949800E-01
Grade 2-vs-Grade 3
5.080200E-01
Grade 2-vs-Grade 4
9.775800E-01
Grade 3-vs-Grade 4
9.525400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.218410E-01
Normal-vs-NonDiabetic
1.711170E-01
Diabetic-vs-NonDiabetic
3.520400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.891400E-01
Normal-vs-NoPancreatitis
1.116170E-01
Pancreatitis-vs-NoPancreatitis
1.376310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.182800E-01
Normal-vs-N1
1.772200E-01
N0-vs-N1
6.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.804000E-01
Normal-vs-TP53-NonMutant
2.985800E-01
TP53-Mutant-vs-TP53-NonMutant
1.165910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
